Elizabeth Holmes, the chief executive of Theranos, a private blood testing start-up, defended the company on Wednesday and said recent reports that questioned the reliability and accuracy of Theranos technology were false.
Ms. Holmes made her remarks during an onstage interview at The Wall Street Journal’s WSJD technology conference. Her comments came after a Wall Street Journal investigation that raised queries about Theranos and its blood-testing technology.
Read Full Article »